Liraglutide Increases VEGF Expression via CNPY2-PERK Pathway Induced by Hypoxia/Reoxygenation Injury
Liraglutide (Lir) is a glucagon-like peptide-1 receptor agonist that lowers blood sugar and reduces myocardial infarct size by improving endothelial cell function. However, its mechanism has not yet been clarified. Unfolded protein response (UPR) plays an important role in the pathogenesis of myocar...
Saved in:
Main Authors: | Chong Liu (Author), Yong Liu (Author), Jing He (Author), Rong Mu (Author), Yanbo Di (Author), Na Shen (Author), Xuan Liu (Author), Xiao Gao (Author), Jinhui Wang (Author), Tie Chen (Author), Tao Fang (Author), Huanming Li (Author), Fengshi Tian (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2019-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Berberine Attenuates Cerebral Ischemia-Reperfusion Injury Induced Neuronal Apoptosis by Down-Regulating the CNPY2 Signaling Pathway
by: Lina Zhao, et al.
Published: (2021) -
The Protective Effect of Quercetin on Endothelial Cells Injured by Hypoxia and Reoxygenation
by: Meng-Ting Li, et al.
Published: (2021) -
Chapter The Hypoxia-Reoxygenation Injury Model
by: Gerő, Domokos
Published: (2017) -
Chapter The Hypoxia-Reoxygenation Injury Model
by: Gerő, Domokos
Published: (2017) -
Myricitrin Protects Cardiomyocytes from Hypoxia/Reoxygenation Injury: Involvement of Heat Shock Protein 90
by: Min Wang, et al.
Published: (2017)